Echo Therapeutics (ECTE) Announces Common Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/30/2026

1. NTAP
2. SPY
3. NVDA
4. MDB
5. FFAI
6. MTN
7. META
8. AIR
9. ORCL
10. SPCX

Go back to Echo Therapeutics (ECTE) Announces Common Offering

Echo Therapeutics (ECTE) Closes 3.2M Offering at 95c/Share

December 27, 2012 4:16 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the closing of a previously announced underwritten public offering of 3,200,000 shares of its common stock and the fully exercised over-allotment option to purchase 480,000 additional shares, offered at a price of $0.95 per share. The gross proceeds to Echo from this offering... More

Echo Therapeutics (ECTE) Underwriters Exercise Full Overallotment in 3.2M Offering

December 26, 2012 4:19 PM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) announced the full exercise of the over-allotment option granted to the underwriters to purchase 480,000 additional common shares, at a public offering price of $0.95 per share, in connection with its previously announced underwritten public offering of 3,200,000 shares of common stock,... More

Echo Therapeutics (ECTE) Prices 3.2M Offering at 95c/Share

December 21, 2012 7:06 AM EST

Echo Therapeutics, Inc. (Nasdaq: ECTE) today announced the pricing of a previously announced underwritten public offering of 3,200,000 shares of its common stock, offered at a price to the public of $0.95 per share. The gross proceeds to Echo from this offering are expected to be approximately $3.0... More